BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 1325771 CC1(CC1)c1ccc2ncc(-c3cccc(NC4CCC5(CNC5)C4)n3)n2c1 InChI=1S/C23H27N5/c1-22(9-10-22)16-5-6-21-25-12-19(28(21)13-16)18-3-2-4-20(27-18)26-17-7-8-23(11-17)14-24-15-23/h2-6,12-13,17,24H,7-11,14-15H2,1H3,(H,26,27) MJGKLMMMXSNBCX-UHFFFAOYSA-N 621080 N-(6-(6-(1-methyl- cyclopropyl)imidazo- [1,2-a]pyridin-3-yl)- pyridin-2-yl)-2- azaspiro[3.4]octan-6- amine::US20230303563, Compound 13 Receptor-type tyrosine-protein kinase FLT3 [572-603] 9.80 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621080&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 163774523 485228241 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325776 FC(F)Oc1ccc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4F)n3)n2c1 InChI=1S/C17H16F3N5O/c18-11-6-21-7-13(11)24-15-3-1-2-12(23-15)14-8-22-16-5-4-10(9-25(14)16)26-17(19)20/h1-5,8-9,11,13,17,21H,6-7H2,(H,23,24)/t11-,13-/m0/s1 GZNUMHPRTTZGTC-AAEUAGOBSA-N 621098 6-(6-(difluorometh- oxy)imidazo[1,2-a]- pyridin-3-yl)-N-((3S, 4S)-4-fluoropyrrolidin- 3-yl)pyridin-2-amine::US20230303563, Compound 53 Receptor-type tyrosine-protein kinase FLT3 [572-603] 1.80 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621098&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 163603259 485228259 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325781 Cn1cc(cn1)-c1ccc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4F)n3)n2c1 InChI=1S/C20H20FN7/c1-27-11-14(7-24-27)13-5-6-20-23-10-18(28(20)12-13)16-3-2-4-19(25-16)26-17-9-22-8-15(17)21/h2-7,10-12,15,17,22H,8-9H2,1H3,(H,25,26)/t15-,17-/m0/s1 RMKCHWNCFUKDKZ-RDJZCZTQSA-N 621166 N-((3S,4S)-4-fluoro- pyrrolidin-3-yl)-6-(6-(1- methyl-1H-pyrazol-4- yl)imidazo[1,2-a]pyridin- 3-yl)pyridin-2-amine::US20230303563, Compound 96 Receptor-type tyrosine-protein kinase FLT3 [572-603] 3.90 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621166&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961746 485228323 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325786 CC(C)(O)Cn1cc(cn1)-c1ccc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4F)n3)n2c1 InChI=1S/C23H26FN7O/c1-23(2,32)14-30-12-16(8-27-30)15-6-7-22-26-11-20(31(22)13-15)18-4-3-5-21(28-18)29-19-10-25-9-17(19)24/h3-8,11-13,17,19,25,32H,9-10,14H2,1-2H3,(H,28,29)/t17-,19-/m0/s1 WYMFRBGEYAFECV-HKUYNNGSSA-N 621167 1-(4-(3-(6-(((3S,4S)-4- fluoropyrrolidin-3-yl)- amino)pyridin-2-yl)- imidazo[1,2-a]pyridin-6- yl)-1H-pyrazol-1-yl)-2- methylpropan-2-ol::US20230303563, Compound 105 Receptor-type tyrosine-protein kinase FLT3 [572-603] 7.00 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621167&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961571 485228324 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325791 F[C@H]1CNC[C@@H]1Nc1cccc(n1)-c1cnc2ccc(cn12)-c1cnn(c1)C1CC1 InChI=1S/C22H22FN7/c23-17-9-24-10-19(17)28-21-3-1-2-18(27-21)20-11-25-22-7-4-14(12-29(20)22)15-8-26-30(13-15)16-5-6-16/h1-4,7-8,11-13,16-17,19,24H,5-6,9-10H2,(H,27,28)/t17-,19-/m0/s1 VKHCEOHPLBYGQD-HKUYNNGSSA-N 621168 6-(6-(1-cyclopropyl-1H- pyrazol-4-yl)imidazo- [1,2-a]pyridin-3-yl)-N- ((3S,4S)-4-fluoro- pyrrolidin-3-yl)pyridin- 2-amine::US20230303563, Compound 106 Receptor-type tyrosine-protein kinase FLT3 [572-603] 4.00 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621168&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961573 485228325 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325796 OCc1cc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4F)n3)n2cc1C1CC1 InChI=1S/C20H22FN5O/c21-15-7-22-8-17(15)25-19-3-1-2-16(24-19)18-9-23-20-6-13(11-27)14(10-26(18)20)12-4-5-12/h1-3,6,9-10,12,15,17,22,27H,4-5,7-8,11H2,(H,24,25)/t15-,17-/m0/s1 WMZGRDMNDXPHMF-RDJZCZTQSA-N 621115 US20230303563, Compound 117 Receptor-type tyrosine-protein kinase FLT3 [572-603] 0.430 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621115&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 169074480 485228276 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325801 CC(C)(O)c1cn2c(cnc2cc1CO)-c1cccc(N[C@H]2CNC[C@@H]2F)n1 InChI=1S/C20H24FN5O2/c1-20(2,28)13-10-26-17(9-23-19(26)6-12(13)11-27)15-4-3-5-18(24-15)25-16-8-22-7-14(16)21/h3-6,9-10,14,16,22,27-28H,7-8,11H2,1-2H3,(H,24,25)/t14-,16-/m0/s1 VMZCRJAQNNOYPK-HOCLYGCPSA-N 621116 2-(3-(6-(((3S,4S)-4- fluoropyrrolidin-3- yl)amino)pyridin-2-yl)-7- methoxyimidazo[1,2- a]pyridin-6-yl)propan-2-ol::US20230303563, Compound 137 Receptor-type tyrosine-protein kinase FLT3 [572-603] 2.40 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621116&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 169074527 485228277 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325806 CC(C)(O)c1cn2c(cnc2cc1CO)-c1cccc(N[C@H]2CNCC[C@@H]2F)n1 InChI=1S/C21H26FN5O2/c1-21(2,29)14-11-27-18(10-24-20(27)8-13(14)12-28)16-4-3-5-19(25-16)26-17-9-23-7-6-15(17)22/h3-5,8,10-11,15,17,23,28-29H,6-7,9,12H2,1-2H3,(H,25,26)/t15-,17-/m0/s1 IQBCZHKBLZWXEM-RDJZCZTQSA-N 621117 2-(3-(6-(((3S,4S)-4- fluoropiperidin-3- yl)amino)pyridin-2-yl)-7- methoxyimidazo[1,2- a]pyridin-6-yl)propan-2-ol::US20230303563, Compound 146 Receptor-type tyrosine-protein kinase FLT3 [572-603] 1.60 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621117&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 169074467 485228278 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325811 FC(F)c1ccc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4F)n3)n2c1 InChI=1S/C17H16F3N5/c18-11-6-21-7-13(11)24-15-3-1-2-12(23-15)14-8-22-16-5-4-10(17(19)20)9-25(14)16/h1-5,8-9,11,13,17,21H,6-7H2,(H,23,24)/t11-,13-/m0/s1 QSSMDRNGJZDMSQ-AAEUAGOBSA-N 621123 US20230303563, Compound 165 Receptor-type tyrosine-protein kinase FLT3 [572-603] 4.90 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621123&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961538 485228284 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325816 FC(F)c1ccc2ncc(-c3cccc(N[C@H]4CNCC44CC4)n3)n2c1 InChI=1S/C19H19F2N5/c20-18(21)12-4-5-17-23-8-14(26(17)10-12)13-2-1-3-16(24-13)25-15-9-22-11-19(15)6-7-19/h1-5,8,10,15,18,22H,6-7,9,11H2,(H,24,25)/t15-/m0/s1 SNNSTEZDXSIKQW-HNNXBMFYSA-N 621125 (R)-N-(6-(6- (difluoromethyl)imidazo[1,2- a]pyridin-3-yl)pyridin-2-yl)-5- azaspiro[2.4]heptan-7-amine::US20230303563, Compound 172 Receptor-type tyrosine-protein kinase FLT3 [572-603] 0.910 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621125&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 163968043 485228286 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325821 FC(F)c1ccc2ncc(-c3cccc(N[C@H]4CNC[C@@H]4C(F)(F)F)n3)n2c1 InChI=1S/C18H16F5N5/c19-17(20)10-4-5-16-25-8-14(28(16)9-10)12-2-1-3-15(26-12)27-13-7-24-6-11(13)18(21,22)23/h1-5,8-9,11,13,17,24H,6-7H2,(H,26,27)/t11-,13-/m0/s1 YGDAYHUWESEYBV-AAEUAGOBSA-N 621126 6-(6- (difluoromethyl)imidazo[1,2- a]pyridin-3-yl)-N-((3R,4S)-4- (trifluoromethyl)pyrrolidin-3- yl)pyridin-2-amine::US20230303563, Compound 175 Receptor-type tyrosine-protein kinase FLT3 [572-603] 1.50 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621126&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961811 485228287 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325826 CC1(C)NCCC1Nc1cccc(n1)-c1cnc2ccc(cn12)C(F)F InChI=1S/C19H21F2N5/c1-19(2)15(8-9-23-19)25-16-5-3-4-13(24-16)14-10-22-17-7-6-12(18(20)21)11-26(14)17/h3-7,10-11,15,18,23H,8-9H2,1-2H3,(H,24,25) VHSYEXAGYXKQAC-UHFFFAOYSA-N 621169 6-(6- (difluoromethyl)imidazo[1,2- a]pyridin-3-yl)-N-(2,2- dimethylpyrrolidin-3- yl)pyridin-2-amine::US20230303563, Compound 178 Receptor-type tyrosine-protein kinase FLT3 [572-603] 3.10 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621169&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961580 485228326 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325831 FC(F)c1ccc2ncc(-c3cccc(NC4CCC5(CNC5)C4)n3)n2c1 InChI=1S/C20H21F2N5/c21-19(22)13-4-5-18-24-9-16(27(18)10-13)15-2-1-3-17(26-15)25-14-6-7-20(8-14)11-23-12-20/h1-5,9-10,14,19,23H,6-8,11-12H2,(H,25,26) YEZSPJXJBLNYQO-UHFFFAOYSA-N 621130 N-(6-(6- (difluoromethyl)imidazo[1,2- a]pyridin-3-yl)pyridin-2-yl)-2- azaspiro[3.4]octan-6-amine::US20230303563, Compound 181 Receptor-type tyrosine-protein kinase FLT3 [572-603] 2.30 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621130&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 164120461 485228291 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325836 CC(C)Oc1ccn2c(cnc2c1)-c1nc(N[C@H]2CNC[C@@H]2F)c(F)cc1F InChI=1S/C19H20F3N5O/c1-10(2)28-11-3-4-27-16(9-24-17(27)5-11)18-12(20)6-13(21)19(26-18)25-15-8-23-7-14(15)22/h3-6,9-10,14-15,23H,7-8H2,1-2H3,(H,25,26)/t14-,15-/m0/s1 OCDYJTRAVKONSS-GJZGRUSLSA-N 621136 3,5-difluoro-N-((3S,4S)-4- fluoropyrrolidin-3-yl)-6- (7- isopropoxyimidazo[1,2- a]pyridin-3-yl)pyridin-2- amine::US20230303563, Compound 207 Receptor-type tyrosine-protein kinase FLT3 [572-603] 11.0 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621136&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 163829148 485228297 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325841 CC(C)Oc1ccn2c(cnc2c1)-c1nc(N[C@H]2CNCC[C@@H]2F)c(F)cc1F InChI=1S/C20H22F3N5O/c1-11(2)29-12-4-6-28-17(10-25-18(28)7-12)19-14(22)8-15(23)20(27-19)26-16-9-24-5-3-13(16)21/h4,6-8,10-11,13,16,24H,3,5,9H2,1-2H3,(H,26,27)/t13-,16-/m0/s1 HCHLTTBJHNWMPS-BBRMVZONSA-N 621137 3,5-difluoro-N-((3S,4S)-4- fluoropiperidin-3-yl)-6-(7- isopropoxyimidazo[1,2- a]pyridin-3-yl)pyridin-2- amine::US20230303563, Compound 208 Receptor-type tyrosine-protein kinase FLT3 [572-603] 3.00 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621137&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961736 485228298 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325846 CC(C)Oc1ccn2c(cnc2c1)-c1cccc(N[C@H]2CNC[C@@H]2F)n1 InChI=1S/C19H22FN5O/c1-12(2)26-13-6-7-25-17(11-22-19(25)8-13)15-4-3-5-18(23-15)24-16-10-21-9-14(16)20/h3-8,11-12,14,16,21H,9-10H2,1-2H3,(H,23,24)/t14-,16-/m0/s1 FUFJXODRNRQIRI-HOCLYGCPSA-N 621161 N-((3S,4S)-4- fluoropyrrolidin-3-yl)-6-(7- isopropoxyimidazo[1,2- a]pyridin-3-yl)pyridin-2- amine::US20230303563, Compound 261 Receptor-type tyrosine-protein kinase FLT3 [572-603] 4.00 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621161&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961710 485228318 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW 1325851 F[C@H]1CNC[C@@H]1Nc1cccc(n1)-c1cnc2cc(ccn12)C1CC1 InChI=1S/C19H20FN5/c20-14-9-21-10-16(14)24-18-3-1-2-15(23-18)17-11-22-19-8-13(12-4-5-12)6-7-25(17)19/h1-3,6-8,11-12,14,16,21H,4-5,9-10H2,(H,23,24)/t14-,16-/m0/s1 OTAZAWFIQUEVLG-HOCLYGCPSA-N 621165 Exemplary Synthetic Procedure #38 ::US20230303563, Compound 269 Receptor-type tyrosine-protein kinase FLT3 [572-603] 1.000 US Patent 10.7270/Q2QF8Z1P US20230303563 HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS CHILDREN''S HOSPITAL MEDICAL CENTER; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN; KUROME THERAPEUTICS, INC. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1483&target=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621165&enzyme=Receptor-type+tyrosine-protein+kinase+FLT3+%5B572-603%5D&column=ki&startPg=0&Increment=50&submit=Search 166961776 485228322 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW